PPARalpha/gamma agonist 3 (Compound 4) is a dual agonist of PPARalpha/gamma. PPARalpha/gamma agonist 3 has anti-inflammatory activity, significantly reducing inflammatory markers such as IL-6 and MCP-1 on THP-1 macrophages through NF-kappaB activation. PPARalpha/gamma agonist 3 can be used in the study of metabolic syndrome and metabolic dysfunction-related fatty liver disease (MAFLD)[1].
Molekulargewicht:
475.58
Formel:
C27H26FN3O2S
Target-Kategorie:
PPAR
Anwendungsbeschreibung:
Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
